Obtenez 3 mois à 0,99 $/mois

OFFRE D'UNE DURÉE LIMITÉE
Page de couverture de A New Frontier in the Co-Management of Thyroid Eye Disease

A New Frontier in the Co-Management of Thyroid Eye Disease

A New Frontier in the Co-Management of Thyroid Eye Disease

Auteur(s): Annenberg Center for Health Sciences
Écouter gratuitement

À propos de cet audio

 Thyroid eye disease, also known as Graves’ orbitopathy, is a potentially serious, progressive autoimmune disease that most often occurs in people with hyperthyroidism, ie, Graves’ disease. Kimberley Cockerham, MD, FACS, moderates this series of six, paired conversations between endocrinologist Terry J. Smith, MD, and eye specialists Wendy W. Lee, MD, and Raymond Douglas, MD, PhD, to explore current and emerging treatment options for thyroid eye disease. In these conversations, faculty review the current understanding of the burden and pathophysiology of thyroid eye disease—including treatmentAnnenberg Center for Health Sciences Hygiène et mode de vie sain Troubles et maladies
Épisodes
  • Radiation, Surgery

    Radiation, Surgery
    Sep 24 2021
    • The role for external beam radiation and orbital decompression in treating patients with thyroid eye disease
    • Other surgical options for treating patients with thyroid eye disease
    Voir plus Voir moins
    13 min
  • Clinical Trials Experience

    Clinical Trials Experience
    Sep 24 2021
    • Clinical data supporting the approval of teprotumumab
    • How efficacy was assessed in the teprotumumab trials
    • Emerging therapies for patients with thyroid eye disease
    Voir plus Voir moins
    16 min
  • Treatment

    Treatment
    Sep 24 2021
    • The role of intervention in patient management
    • Therapy selection for patients with thyroid eye disease
    • Evaluating treatment responses
    Voir plus Voir moins
    15 min
Pas encore de commentaire